awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37311579-0E9455B0-0869-42CB-9F0C-583279369819
Q37311579-0E9455B0-0869-42CB-9F0C-583279369819
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37311579-0E9455B0-0869-42CB-9F0C-583279369819
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
P2860
Q37311579-0E9455B0-0869-42CB-9F0C-583279369819
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37311579-0E9455B0-0869-42CB-9F0C-583279369819
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
07810616bab9047e9635aef85a4b4ceb40c318a2
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.